GP Combined With Nimotuzumab and Sintilimab as Induction Therapy for Nasopharyngeal Carcinoma
Clinical trial NCT06490341 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06490341
- Sponsor
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-07-20
- Primary completion
- 2026-07-20
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.